Literature DB >> 17827392

CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages.

Eric Vachon1, Raiza Martin, Vivian Kwok, Vera Cherepanov, Chung-Wai Chow, Claire M Doerschuk, Jonathan Plumb, Sergio Grinstein, Gregory P Downey.   

Abstract

Diverse receptors, including Fcgamma receptors and beta(2) integrins (complement receptor-3 [CR3], CD11b/CD18), have been implicated in phagocytosis, but their distinct roles and interactions with other receptors in particle engulfment are not well defined. CD44, a transmembrane adhesion molecule involved in binding and metabolism of hyaluronan, may have additional functions in regulation of inflammation and phagocytosis. We have recently reported that CD44 is a fully competent phagocytic receptor that is able to trigger ingestion of large particles by macrophages. Here, we investigated the role of coreceptors and intracellular signaling pathways in modulation of CD44-mediated phagocytosis. Using biotinylated erythrocytes coated with specific antibodies (anti-CD44-coated erythrocytes [Ebabs]) as the phagocytic prey, we determined that CD44-mediated phagocytosis is reduced by 45% by a blocking CD11b antibody. Further, CD44-mediated phagocytosis was substantially (42%) reduced in CD18-null mice. Immunofluorescence microscopy revealed that CD11b is recruited to the phagocytic cup. The mechanism of integrin activation and mobilization involved activation of the GTPase Rap1. CD44-mediated phagocytosis was also sensitive to the extracellular concentration of the divalent cation Mg(2+) but not Ca(2+). In addition, buffering of intracellular Ca(2+) did not affect CD44-mediated phagocytosis. Taken together, these data suggest that CD44 stimulation induces inside-out activation of CR3 through the GTPase Rap1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827392      PMCID: PMC2234794          DOI: 10.1182/blood-2007-02-076539

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  74 in total

1.  Phorbol ester induces transient focal concentrations of functional, newly expressed CR3 in neutrophils at sites of specific granule exocytosis.

Authors:  K B Pryzwansky; T Wyatt; W Reed; G D Ross
Journal:  Eur J Cell Biol       Date:  1991-02       Impact factor: 4.492

Review 2.  CR2 complement receptor.

Authors:  N R Cooper; B M Bradt; J S Rhim; G R Nemerow
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

Review 3.  Receptor-receptor interactions of complement receptor type 3 in neutrophil membranes.

Authors:  H R Petty; R F Todd
Journal:  J Leukoc Biol       Date:  1993-11       Impact factor: 4.962

4.  Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway.

Authors:  G Koopman; Y van Kooyk; M de Graaff; C J Meyer; C G Figdor; S T Pals
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

5.  Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.

Authors:  W A Lynn; C R Raetz; N Qureshi; D T Golenbock
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

6.  Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins.

Authors:  E Brown; L Hooper; T Ho; H Gresham
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

7.  Extracellular calcium results in a conformational change in Mac-1 (CD11b/CD18) on neutrophils. Differentiation of adhesion and phagocytosis functions of Mac-1.

Authors:  I L Graham; E J Brown
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

8.  Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes.

Authors:  G D Ross; W Reed; J G Dalzell; S E Becker; N Hogg
Journal:  J Leukoc Biol       Date:  1992-02       Impact factor: 4.962

Review 9.  Leukocyte adhesion deficiency syndrome: insights into the molecular basis of leukocyte emigration.

Authors:  J M Harlan
Journal:  Clin Immunol Immunopathol       Date:  1993-06

10.  Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18).

Authors:  D M Mosser; T A Springer; M S Diamond
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  23 in total

1.  The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration.

Authors:  Ke Zen; Dan-Qing Liu; Li-Min Li; Celia X-J Chen; Ya-Lan Guo; Bihn Ha; Xi Chen; Chen-Yu Zhang; Yuan Liu
Journal:  J Biol Chem       Date:  2008-12-10       Impact factor: 5.157

2.  HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.

Authors:  Davor Frleta; Carolyn E Ochoa; Holger B Kramer; Shaukat Ali Khan; Andrea R Stacey; Persephone Borrow; Benedikt M Kessler; Barton F Haynes; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

3.  Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells.

Authors:  Sai P Thankamony; Robert Sackstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-21       Impact factor: 11.205

4.  CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi.

Authors:  Kelly L Hawley; Chris M Olson; Juan M Iglesias-Pedraz; Nicolás Navasa; Jorge L Cervantes; Melissa J Caimano; Hooman Izadi; Robin R Ingalls; Utpal Pal; Juan C Salazar; Justin D Radolf; Juan Anguita
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

5.  Cleavage of the CD11b extracellular domain by the leukocyte serprocidins is critical for neutrophil detachment during chemotaxis.

Authors:  Ke Zen; Ya-Lan Guo; Li-Min Li; Zhen Bian; Chen-Yu Zhang; Yuan Liu
Journal:  Blood       Date:  2011-03-14       Impact factor: 22.113

6.  sCD44 internalization in human trabecular meshwork cells.

Authors:  Michael J Nolan; Tomoyo Koga; Loyal Walker; Ryan McCarty; Algis Grybauskas; Michael C Giovingo; Kevin Skuran; Paulius V Kuprys; Paul A Knepper
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

7.  Mechanisms of interferon-γ production by neutrophils and its function during Streptococcus pneumoniae pneumonia.

Authors:  John C Gomez; Mitsuhiro Yamada; Jessica R Martin; Hong Dang; W June Brickey; Wolfgang Bergmeier; Mary C Dinauer; Claire M Doerschuk
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914

8.  Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.

Authors:  Santosh K Panda; Valeria Facchinetti; Elisaveta Voynova; Shino Hanabuchi; Jodi L Karnell; Richard N Hanna; Roland Kolbeck; Miguel A Sanjuan; Rachel Ettinger; Yong-Jun Liu
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

9.  The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.

Authors:  Bing Ren; Jie Li; Kristopher Genschmer; Susan K Hollingshead; David E Briles
Journal:  Clin Vaccine Immunol       Date:  2012-08-01

10.  COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.

Authors:  Robert Lorenz Chua; Soeren Lukassen; Saskia Trump; Bianca P Hennig; Daniel Wendisch; Fabian Pott; Olivia Debnath; Loreen Thürmann; Florian Kurth; Maria Theresa Völker; Julia Kazmierski; Bernd Timmermann; Sven Twardziok; Stefan Schneider; Felix Machleidt; Holger Müller-Redetzky; Melanie Maier; Alexander Krannich; Sein Schmidt; Felix Balzer; Johannes Liebig; Jennifer Loske; Norbert Suttorp; Jürgen Eils; Naveed Ishaque; Uwe Gerd Liebert; Christof von Kalle; Andreas Hocke; Martin Witzenrath; Christine Goffinet; Christian Drosten; Sven Laudi; Irina Lehmann; Christian Conrad; Leif-Erik Sander; Roland Eils
Journal:  Nat Biotechnol       Date:  2020-06-26       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.